Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed125%
unknown250%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

NCT03856086
terminated

Cognitive Changes With Gabapentin Treatment

NCT04106011
unknown

Prevalence of Neuropsychiatric Manifestations in IBD Patients in Upper Egypt

NCT04573400
unknownnot_applicable

Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic

NCT04406181

Clinical Trials (4)

Showing 4 of 4 trials
NCT03856086Not Applicable

Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients

Completed
NCT04106011

Cognitive Changes With Gabapentin Treatment

Terminated
NCT04573400

Prevalence of Neuropsychiatric Manifestations in IBD Patients in Upper Egypt

Unknown
NCT04406181Not Applicable

Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic

Unknown

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4